Eiger BioPharmaceuticals Acquires Celladon for Undisclosed Sum

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    12760 High Bluff Drive San Diego, CA 92130 USA
  • Company Description
    Celladon Corporation is an exciting new biotechnology company focused on developing treatments for cardiovascular diseases through the application of scientific discoveries in molecular cardiology.
  • Website
  • Transaction Type
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
  • M&A Terms
    The proposed merger will create a clinical-stage company with a diversified development portfolio of product candidates addressing novel targets for four distinct orphan diseases: Hepatitis Delta Virus, bariatric surgery-induced hyperinsulinemic hypoglycemia, pulmonary arterial hypertension, and lymphedema.

Trending on Xconomy